19-13259589-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_001127222.2(CACNA1A):c.4363G>A(p.Val1455Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,456,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1455L) has been classified as Pathogenic.
Frequency
Consequence
NM_001127222.2 missense
Scores
Clinical Significance
Conservation
Publications
- episodic ataxia type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- developmental and epileptic encephalopathy, 42Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- migraine, familial hemiplegic, 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia type 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- benign paroxysmal torticollis of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial or sporadic hemiplegic migraineInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1A | ENST00000360228.11 | c.4363G>A | p.Val1455Met | missense_variant | Exon 27 of 47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
| CACNA1A | ENST00000638029.1 | c.4375G>A | p.Val1459Met | missense_variant | Exon 27 of 48 | 5 | ENSP00000489829.1 | |||
| CACNA1A | ENST00000573710.7 | c.4369G>A | p.Val1457Met | missense_variant | Exon 27 of 47 | 5 | ENSP00000460092.3 | |||
| CACNA1A | ENST00000635727.1 | c.4366G>A | p.Val1456Met | missense_variant | Exon 27 of 47 | 5 | ENSP00000490001.1 | |||
| CACNA1A | ENST00000637769.1 | c.4366G>A | p.Val1456Met | missense_variant | Exon 27 of 47 | 1 | ENSP00000489778.1 | |||
| CACNA1A | ENST00000636012.1 | c.4366G>A | p.Val1456Met | missense_variant | Exon 27 of 46 | 5 | ENSP00000490223.1 | |||
| CACNA1A | ENST00000637736.1 | c.4225G>A | p.Val1409Met | missense_variant | Exon 26 of 46 | 5 | ENSP00000489861.1 | |||
| CACNA1A | ENST00000636389.1 | c.4366G>A | p.Val1456Met | missense_variant | Exon 27 of 47 | 5 | ENSP00000489992.1 | |||
| CACNA1A | ENST00000637432.1 | c.4375G>A | p.Val1459Met | missense_variant | Exon 27 of 48 | 5 | ENSP00000490617.1 | |||
| CACNA1A | ENST00000636549.1 | c.4366G>A | p.Val1456Met | missense_variant | Exon 27 of 48 | 5 | ENSP00000490578.1 | |||
| CACNA1A | ENST00000637927.1 | c.4369G>A | p.Val1457Met | missense_variant | Exon 27 of 47 | 5 | ENSP00000489715.1 | |||
| CACNA1A | ENST00000635895.1 | c.4366G>A | p.Val1456Met | missense_variant | Exon 27 of 47 | 5 | ENSP00000490323.1 | |||
| CACNA1A | ENST00000638009.2 | c.4366G>A | p.Val1456Met | missense_variant | Exon 27 of 47 | 1 | ENSP00000489913.1 | |||
| CACNA1A | ENST00000637276.1 | c.4366G>A | p.Val1456Met | missense_variant | Exon 27 of 46 | 5 | ENSP00000489777.1 | |||
| CACNA1A | ENST00000636768.2 | n.4366G>A | non_coding_transcript_exon_variant | Exon 27 of 45 | 5 | ENSP00000490190.2 | ||||
| CACNA1A | ENST00000713789.1 | n.4363G>A | non_coding_transcript_exon_variant | Exon 27 of 47 | ENSP00000519091.1 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1456912Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 724178 show subpopulations
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Val1456 amino acid residue in CACNA1A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10408532, 10734061). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1A protein function. ClinVar contains an entry for this variant (Variation ID: 946947). This variant has not been reported in the literature in individuals affected with CACNA1A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1456 of the CACNA1A protein (p.Val1456Met). -
Seizure Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at